BlackRock Investment Management, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$14,000
+180.0%
2,6500.0%0.00%
Q3 2016$5,0000.0%2,650
+15.9%
0.00%
Q2 2016$5,0000.0%2,2870.0%0.00%
Q1 2016$5,000
-28.6%
2,2870.0%0.00%
Q4 2015$7,000
-30.0%
2,2870.0%0.00%
Q3 2015$10,000
-16.7%
2,2870.0%0.00%
Q2 2015$12,0000.0%2,287
+40.0%
0.00%
Q1 2015$12,000
+9.1%
1,6330.0%0.00%
Q4 2014$11,0000.0%1,633
-7.3%
0.00%
Q3 2014$11,000
-26.7%
1,761
+8.4%
0.00%
Q2 2014$15,000
-89.6%
1,625
-90.8%
0.00%
Q1 2014$144,000
+39.8%
17,700
+10.3%
0.00%
Q4 2013$103,000
+9.6%
16,042
+70.8%
0.00%
Q3 2013$94,0009,3920.00%
Other shareholders

There were no reported owners of CONATUS PHARMACEUTICALS INC in Q2 2015.

NameSharesValueWeighting ↓
View complete list of CONATUS PHARMACEUTICALS INC shareholders